Medacta Corporate
New Data and Milestones Back Medacta's Orthopedic Surgery Product Line Following 8th M.O.R.E. International Symposium

New Data and Milestones Back Medacta's Orthopedic Surgery Product Line Following 8th M.O.R.E. International Symposium

Proud to share new data and milestones of key products following the 8th M.O.R.E. Symposium in Lugano, Switzerland!

 

 

The high adoption rate of Medacta’s surgical products and promising clinical data reviewed at the M.O.R.E. Symposium are testaments to the work we’re doing to improve the orthopedic experience both for patients and surgeons,” said Francesco Siccardi, Executive Vice President of Medacta International. “The positive feedback we’ve received for AMIStem and continued enthusiasm for GMK Sphere, MyKnee and MySpine suggest there is a clear need for products that combine meticulous design, responsible innovation and a commitment to health-economic sustainability.

  • More than 200,000 AMIS procedures completed and 100,000 AMIStem implants used, as new data demonstrate ODEP quality
  • More than 40,000 MyKnee procedures performed to date, providing superior function and accuracy
  • Over 15,000 GMK Sphere knees implanted since 2011, comparing favorably against other ODEP-rated implant designs
  • MySpine pedicle screw placement yields promising results

Read more on BusinessWire